HomeResearch studiesWhat is ketamine?

What is ReDKITE?

ReDKITE is a collaboration between clinicians and researchers across the UK exploring the use of low dose ketamine as a possible treatment for treatment resistant depression.

ReDKITE stands for Resistant Depression - Ketamine Infusion Treatment Evaluation.

Members are from all across the UK with clinics in Oxford and 1 or 2 other centres currently exploring the use of ketamine in treatment resistant depression.

The Redkite Collaboration would like to hear from patients and others who are interested in this area.  Please register this interest by following the link below.  Your responses may be aggregated and anonymously published.


Questions or comments? Get in touch with us at: